Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab (POSIBA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01276379
Recruitment Status : Active, not recruiting
First Posted : January 13, 2011
Last Update Posted : October 18, 2017
Information provided by (Responsible Party):
Grupo Espanol Multidisciplinario del Cancer Digestivo

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : March 30, 2017
  Estimated Study Completion Date : December 2017